NasdaqGS - Delayed Quote USD

Sabra Health Care REIT, Inc. (SBRA)

14.34 +0.12 (+0.84%)
At close: May 3 at 4:00 PM EDT
14.40 +0.05 (+0.35%)
Pre-Market: 8:00 AM EDT
Loading Chart for SBRA
DELL
  • Previous Close 14.22
  • Open 14.37
  • Bid 14.32 x 700
  • Ask 14.36 x 900
  • Day's Range 14.14 - 14.46
  • 52 Week Range 10.30 - 14.91
  • Volume 1,597,824
  • Avg. Volume 2,059,456
  • Market Cap (intraday) 3.32B
  • Beta (5Y Monthly) 1.17
  • PE Ratio (TTM) 239.00
  • EPS (TTM) 0.06
  • Earnings Date May 8, 2024
  • Forward Dividend & Yield 1.20 (8.36%)
  • Ex-Dividend Date Feb 12, 2024
  • 1y Target Est 15.91

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (“Senior Housing - Leased”), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (“Senior Housing - Managed”), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2023, Sabra's real estate properties held for investment included 37,606 beds/units, spread across the United States and Canada.

www.sabrahealth.com

48

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SBRA

Performance Overview: SBRA

Trailing total returns as of 5/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SBRA
2.71%
S&P 500
7.50%

1-Year Return

SBRA
41.09%
S&P 500
24.47%

3-Year Return

SBRA
2.60%
S&P 500
22.64%

5-Year Return

SBRA
12.40%
S&P 500
75.76%

Compare To: SBRA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SBRA

Valuation Measures

Annual
As of 5/3/2024
  • Market Cap

    3.32B

  • Enterprise Value

    5.69B

  • Trailing P/E

    239.17

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.16

  • Price/Book (mrq)

    1.19

  • Enterprise Value/Revenue

    8.79

  • Enterprise Value/EBITDA

    18.26

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.13%

  • Return on Assets (ttm)

    2.45%

  • Return on Equity (ttm)

    0.47%

  • Revenue (ttm)

    644.62M

  • Net Income Avi to Common (ttm)

    13.76M

  • Diluted EPS (ttm)

    0.06

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    60.2M

  • Total Debt/Equity (mrq)

    86.59%

  • Levered Free Cash Flow (ttm)

    245.38M

Research Analysis: SBRA

Company Insights: SBRA

Research Reports: SBRA

People Also Watch